Development & Positioning Strategy
Can we use basket trials to expand our EU label into multiple rare diseases?
Our client, a European biopharmaceutical company, had never initiated basket trials previously, and wanted our help to understand if and how they could use this innovative trial design to validate their drug in multiple orphan diseases simultaneously.
We evaluated the scientific and commercial opportunity in each indication, using interviews with leading physicians, payers and regulators to test feasibility, and design an innovative translational program focused on access and commercial success.
< Previous Case Study
Next Case Study >